Company Number: 14334638

Analysis Date: 2025-07-20 13:21 UTC

1. Industry Classification

YSM PHARMA LTD operates under SIC code 47730, classified as "Dispensing chemist in specialised stores." This sector falls within the broader retail trade industry but focuses specifically on pharmacies that dispense prescription medicines and operate in specialized retail environments. Key characteristics of this sector include strict regulatory compliance (e.g., Medicines and Healthcare products Regulatory Agency - MHRA), a strong emphasis on customer trust, and relationships with healthcare providers. The sector is generally fragmented with a mix of large pharmacy chains and smaller independent or niche operators.

2. Relative Performance

YSM PHARMA LTD is a micro-entity, reflecting very small scale operations with limited financial reporting requirements. Its financials show modest growth: net assets increased from £5,417 in 2023 to £16,861 in 2024, supported by rising current assets (£30,296 in 2024 vs £17,155 in 2023) and stable liabilities. The company employs on average 1 person, highlighting a lean operational model typical for micro-businesses in this sector.

Compared to typical dispensing chemists, which often have considerable inventory, higher turnover, and multiple employees, YSM PHARMA LTD is at the lower end of scale and capacity. Larger competitors in the sector usually report millions in revenue and significantly higher asset bases. The company’s net assets and working capital position are positive, indicating sound short-term financial health, but its scale is minimal relative to industry benchmarks.

3. Sector Trends Impact

The dispensing chemist sector faces evolving trends such as increased digital health integration, evolving patient expectations for convenience (e.g., online ordering and home delivery), and regulatory pressures to ensure safety and compliance. Additionally, the NHS’s ongoing contract negotiations and reimbursement terms heavily influence margins and profitability.

For a micro-entity like YSM PHARMA LTD, these trends represent both challenges and opportunities. On one hand, limited scale may restrict investment in digital infrastructure or expansion. On the other hand, niche specialization or personalized service in a specialized store format can create differentiation. The sector’s regulatory environment demands robust compliance even from small operators, which can impose fixed costs disproportionate to size.

4. Competitive Positioning

Strengths:

• Positive net assets and growing working capital indicate financial prudence.
• Specialized store classification could imply a niche focus, potentially attracting loyal customers.
• Low headcount and micro-entity status allow for minimal overheads and flexible operations.

Weaknesses:

• Extremely small scale limits purchasing power and economies of scale compared to larger chains (e.g., Boots, LloydsPharmacy).
• Limited resources may restrict ability to invest in technology or expand service offerings.
• Lack of audited financials and minimal disclosures reduce transparency to potential partners or investors.

Overall, YSM PHARMA LTD appears to be a niche, micro-scale player in the dispensing chemist sector, likely focused on a narrow market segment or localized customer base. While financially stable at its scale, it faces significant competitive pressures from larger chains that benefit from scale, brand recognition, and broader service portfolios.